NRX Pharmaceuticals Inc banner

NRX Pharmaceuticals Inc
F:B1Q

Watchlist Manager
NRX Pharmaceuticals Inc Logo
NRX Pharmaceuticals Inc
F:B1Q
Watchlist
Price: 2.955 EUR -4.06% Market Closed
Market Cap: €83m

Wall St Price Targets

B1Q Price Targets Summary
NRX Pharmaceuticals Inc

There are no price targets for B1Q.
Lowest Forecast
Price Target
Not Available
Average Forecast
Price Target
Not Available
Highest Forecast
Price Target
Not Available
NRX Pharmaceuticals Inc Competitors:
Price Targets
SUDEEPPHRM
Sudeep Pharma Ltd
-40% Downside
CIFR
Cipher Mining Inc
94% Upside
CCOI
Cogent Communications Holdings Inc
137% Upside

Revenue
Forecast

N/A
Past Growth
245% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
245% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Revenue over the next 6 years is 245%.

Gross Profit
Forecast

N/A
Past Growth
264% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss
N/A
Past Growth
264% / Year
Estimated Growth
N/A
Estimates Accuracy
N/A
Average Beat/Miss

The compound annual growth rate for Gross Profit over the next 6 years is 264%.

Operating Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-5%
Average Miss

Pre-Tax Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
7%
Average Beat

Net Income
Forecast

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-8%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.

What is B1Q's stock price target?
Not Available

B1Q does not have any price targets made by Wall Street professionals.

What is the Revenue forecast for NRX Pharmaceuticals Inc?
Projected CAGR
245%

The compound annual growth rate for Revenue over the next 6 years is 245%.

What is the Gross Profit forecast for NRX Pharmaceuticals Inc?
Projected CAGR
264%

The compound annual growth rate for Gross Profit over the next 6 years is 264%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett